1. License to Cure for BioPharma

License to Cure for BioPharma

Accelerate therapeutic development, approval, manufacturing, and supply, in a global landscape

available on premise

Pharmaceutical and Biotechnology companies are challenged with the ability to deliver operational excellence with full traceability and to efficiently manage the ever changing global regulatory environment.  License to Cure for BioPharma is an Industry Solution Experience that uniquely provides the ability to accelerate therapeutic development, approval, manufacturing, and supply, in a global landscape by leveraging an extensive, connected and comprehensive regulatory and quality platform.

License to Cure for BioPharma provides digital continuity for organizations to manage the complexity of an ever increasing number of medicinal products with a single version of the truth based on IDMP standards and enables change impact analysis, informed decision making and full IP reuse to deliver quality best practices shifting the paradigm of regulatory as a constraint to regulatory as an asset.

3 minutes 22

Benefits of License to Cure for BioPharma

  • Reduce time to market and cost of market expansion in BioPharma

    Transition from a traditional product oriented model to the delivery of therapeutic solutions using a system that enables companies to be more reactive to quickly meet today's market needs.

  • Leverage Regulatory Intelligence to Drive Your Global Strategy in BioPharma

    Spend less time, reduce the risk of non-compliance, improve traceability and accelerate global expansion

  • Enhance Decision-Making in BioPharma

    Enhance decision-making through real-time views across the lifecycle of innovation

  • Ensure a consistent approach to quality, compliance, and regulatory activities for BioPharma

    The 3DEXPERIENCE® platform enables businesses to transition from historical and outdated practices to a connected and transformative environment across your extended ecosystem.

Adopt the Power of License to Cure for BioPharma

License to Cure for BioPharma provides digital continuity for organizations to manage the complexity of an ever increasing number of medicinal products with a single version of the truth.

Success story

How Digital Transformation Drives Change and Collaboration in the Lab

Learn how Biogen addressed a challenge that is common with many pharma and biopharmaceutical companies: how to reduce inefficiency and improve the delivery of crucial documentation.

Life Sciences Industry > Collaboration in the Lab > Dassault Systèmes®